Search

everythinglearnresearchcommunity

for

Search:↓

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Nanoparticle systems make cancer treatment less toxic.

New delivery systems are improving siRNA treatments for skin conditions.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Targeting lipid metabolism can help treat advanced, resistant cancers.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

A new therapy for a skin blistering condition has not been developed yet.

Data-driven methods can effectively identify existing drugs for new uses, especially in cancer, infections, and respiratory diseases.

Targeting hair follicles can improve skin treatments and reduce side effects.

Exosome-based treatments may improve skin and hair issues, but more research is needed for safety and effectiveness.

Five molecular elements identified as potential future targets for hair loss therapy.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

A new AI-driven method shows promise for treating hair loss with a peptide-based drug.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

The conclusion is that analyzing RNA from skin oils is a promising way to understand skin diseases.

Targeting Keratin 17 may help overcome cancer therapy resistance.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.